How Big Is the Lung Biopsy Market | Growth, Value & Future Trends 2026

Q: What is the expected market size of the lung biopsy market?

The lung biopsy market is projected to exceed USD 3.4 billion by 2032, driven by the rising need for early and accurate respiratory disease diagnostics.

Q: Who are the key players in the lung biopsy market?

Major companies include Medtronic, Olympus, Boston Scientific, Cook Medical, Becton Dickinson, and Veran Medical, known for their diagnostic tool innovations.

Q: What technological trends are impacting the lung biopsy market?

Advancements in robotic biopsy systems, AI-assisted imaging, and real-time navigation are enhancing procedural outcomes in the lung biopsy market.

Q: How is the healthcare sector influencing the lung biopsy market?

The sector is emphasizing non-invasive diagnostics, improving infrastructure, and adopting smart technologies, all contributing to lung biopsy adoption.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6963

Publication Date: Jul 2025

How Big Is the Lung Biopsy Market?

According to 6Wresearch internal database and industry insights, the lung biopsy market was valued at USD 1.9 billion in 2025 and is estimated to exceed USD 3.4 billion by 2032, progressing at a CAGR of 8.4%.

This growth can be attributed to the rising prevalence of lung cancer and respiratory disorders, an increase in demand for minimally invasive diagnostic procedures, and advances in imaging and robotic-guided biopsy technologies. The growing awareness surrounding early cancer detection is also contributing to the growing uptake of diagnostic procedures by diagnostic centers and hospitals.

Growth Factors of the Lung Biopsy Market

Rising lung cancer cases are creating demand for accurate diagnostics
Preference for minimally invasive biopsy procedures is growing
Improvements in imaging technologies enhance procedural precision
Government initiatives are encouraging cancer screening programs
Increasing healthcare infrastructure investments in emerging markets
Surge in demand from ambulatory and outpatient diagnostic centers

Lung Biopsy Market Trends

The lung biopsy market is progressing to image-guided and robot-assisted techniques for tissue sampling accuracy and precision. The use of liquid biopsy continues to grow in adoption as an additional diagnostic option. Healthcare Educators and Providers are using Artificial Intelligence to assist with biopsy planning and analysis, which improves the accuracy of diagnostic outcomes while implementing a variety of ways to reduce risk.

Emerging Developments in the Lung Biopsy Market

Recent advancements in the Lung Biopsy Market include the combination of real-time 3D navigation systems, sophisticated endoscopic ultrasound-guided biopsy tools, and cloud-enabled platforms for the analysis of biopsy data. In addition, vendors are looking to develop portable biopsy devices that focus on utilizing outpatient care settings. Further, collaborations with diagnostic labs and research institutions are accelerating clinical trials and innovation.